Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis b
Phenotype |hepatocellular carcinoma
Sentences 150
PubMedID- 22675319 The expression of dlk1-dio3 mirna was examined in 97 patients with hepatocellular carcinoma (hcc) associated with hepatitis b infection.
PubMedID- 20368541 This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis b.
PubMedID- 23213040 Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis b virus infection.
PubMedID- 23090836 Role of leptin receptor (lepr) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis b virus infection.
PubMedID- 23098862 Chronic infection with the hepatitis b virus can lead to hepatocellular carcinoma and cirrhosis in up to 25% of infected individuals.
PubMedID- 22212935 Prevention of hepatocellular carcinoma in patients with chronic hepatitis b virus infection.
PubMedID- 23853347 Liver cirrhosis and/or hepatocellular carcinoma develops in 15-40% of chronic hepatitis b virus infected patients without treatment.
PubMedID- 23898389 Patients less than 18 years old; patients with neoplasm including hemangioma, liver cyst, and hepatocellular carcinoma; coinfection of hepatitis b and c; hepatitis b healthy carrier with normal transaminase; alcoholic liver disease (20 g/day or more for males, 10 g/day or more for females); autoimmune hepatitis; and metabolic liver diseases such as wilson's disease were other criteria of exclusion.
PubMedID- 24254306 Promoter hypermethylation of p14 (arf) , rb, and ink4 gene family in hepatocellular carcinoma with hepatitis b virus infection.
PubMedID- 24023999 A 49 year-old woman (160.0 cm, 94.6 kg) suffering from hepatocellular carcinoma with end-stage hepatitis b liver cirrhosis (model for end stage liver disease [meld] score 14, child-pugh class b) presented for living donor lt. she had hypertension that was well controlled with medications.
PubMedID- 24101445 This study attempted to evaluate any possible association among tnf-alpha (-308g>a) and ifn-gamma (+874t/a) genotypes, the spontaneous blood and mrna levels and expression of their major signal transducers, namely stat1 and nf-small ka, cyrillicb with hepatitis b virus-induced hepatocellular carcinoma (hcc) susceptibility in india.
PubMedID- 26491439 Additionally, sex hormones play critical roles in the development and progression of many types of cancer, such as hepatocellular carcinoma associated with hepatitis b virus infection (m. montella et al.)
PubMedID- 22712471 Background: a recent genome-wide association study (gwas) using chronic hbv (hepatitis b virus) carriers with and without hepatocellular carcinoma (hcc) in five independent chinese populations found that one snp (rs17401966) in kif1b was associated with susceptibility to hcc.
PubMedID- 20180955 We describe a rare case of tertiary syphilis in a hemodialyzed diabetic patient whom was career of chronic liver disease due to the evolution of chronic hepatitis b virus infection complicated by a hepatocellular carcinoma.
PubMedID- 24128413 Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis b.
PubMedID- 23683438 Reported that mir-148a was upregulated in hepatitis b cells associated with hepatocellular carcinoma (hcc) [27].
PubMedID- 24583062 Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis b treated with entecavir vs lamivudine.
PubMedID- 22946841 The objective of the present study was to explore the common and specific metabolic alterations of hepatocellular carcinoma (hcc) infected with hepatitis b virus (hbv) or hepatitis c virus (hcv).
PubMedID- 24918150 Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis b.
PubMedID- 22436980 Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis b virus infection--results from a clinic-based longitudinal cohort.
PubMedID- 23280722 Il17a gene polymorphisms, serum il-17a and ige levels, and hepatocellular carcinoma risk in patients with chronic hepatitis b virus infection.
PubMedID- 24122900 Does long-term entecavir treatment really reduce hepatocellular carcinoma incidence in patients with hepatitis b virus infection.
PubMedID- 23945731 Random-effects inverse variance meta-analysis of antiviral therapy treatment effects on hepatocellular carcinoma in patients with chronic hepatitis b and cirrhosis, subgroups according to trial design.
PubMedID- 24020023 Indications for living-donor liver transplantation in these patients were hepatitis b cirrhosis with hepatocellular carcinoma (n = 8), hepatitis b cirrhosis without hepatocellular carcinoma (n = 3), autoimmune disease (n = 1), and wilson's disease (n = 2).
PubMedID- 22372460 hepatocellular carcinoma (hcc) in a patient with hepatitis b virus (hbv) infection.
PubMedID- 23583669 Mutations in tp53, ctnnb1 and pik3ca genes in hepatocellular carcinoma associated with hepatitis b and hepatitis c virus infections.
PubMedID- 21809355 We aimed to investigate the incidence of occult hepatitis b infection (obi) in patients with "cryptogenic" hepatocellular carcinoma (hcc) and to study the hbv replicative activity in these patients.
PubMedID- 23225825 The present study was approved by our ethics committee and written informed consent was obtained from all 48 male patients scheduled for liver transplantation for cirrhosis or hepatocellular carcinoma with chronic hepatitis b virus infection.
PubMedID- 26293077 hepatocellular carcinoma in the setting of chronic hepatitis b virus infection: tumor recurrence and survival rates after liver transplantation.
PubMedID- 23236406 The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis b virus infection and cirrhosis.
PubMedID- 24976705 hepatitis b virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy.
PubMedID- 25803433 Tsan et al used this definition to study statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection [24].
PubMedID- 22972059 Objectives: to determine the beneficial and harmful effects of alpha-foetoprotein or ultrasound, or both, for screening of hepatocellular carcinoma in patients with chronic hepatitis b virus infection.
PubMedID- 26064099 Three patients (27%) had other extracolonic cancers or hematologic malignancies: one with hepatocellular carcinoma (hcc) associated with chronic hepatitis b, one with lung cancer, and one with myelodysplastic syndrome (mds).
PubMedID- 23781497 Evaluated the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection and found that the c > t polymorphisms at foki position in the vdr gene served as a potential biomarker for the risk and the disease severity of hcc in those infected with hbv.
PubMedID- 21859997 Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis b and c.
PubMedID- 25894298 Aflatoxin levels in chronic hepatitis b patients with cirrhosis or hepatocellular carcinoma in balikesir, turkey.
PubMedID- 24570914 Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis b virus infection.
PubMedID- 26159441 Background: this study was designed to evaluate the prognostic value of three systemic inflammation markers, neutrophil to lymphocyte ratio (nlr), platelet to lymphocyte ratio (plr), and prognostic nutritional index (pni), for hepatocellular carcinoma (hcc) associated with hepatitis b (hbv).
PubMedID- 26421419 Background: hepatectomy in hepatocellular carcinoma (hcc) patients lead to postoperative hepatitis b virus (hbv) reactivation (phr) as well as immunosuppression.
PubMedID- 22957763 A high incidence of tumor recurrence and metastasis has been reported in hepatocellular carcinoma (hcc) patients with chronic hepatitis b virus (hbv) infection.
PubMedID- 21160825 Skull metastasis from hepatocellular carcinoma with chronic hepatitis b.
PubMedID- 24248733 Microrna-196a-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 24130799 Despite this, several studies hint at differences in expression of mir-122, a liver-specific microrna with tumor suppressor properties, in hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv) versus hepatitis c virus (hcv) infection.
PubMedID- 23044807 Association of xrcc1, xrcc3, and xpd genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis b and c virus.
PubMedID- 25521761 Here, we profiled the mutations and gene expressions of early and advanced hepatocellular carcinoma (hcc) related with hepatitis b-viral infection.
PubMedID- 25478255 A 62-year-old woman, with cirrhosis due to hepatitis b associated with hepatocellular carcinoma, was submitted to living donor liver transplantation.
PubMedID- 21910010 Aim: to compare clinical and radiological findings of newly diagnosed hepatocellular carcinomas (hccs) in patients with chronic hepatitis b virus (hbv) and chronic hepatitis c virus (hcv) infections.
PubMedID- 25915736 In a population-based study examining hdac10 polymorphisms it was found that one variant that resulted in increased expression of hdac10 protein also corresponded with an increased occurrence and accelerated onset of hepatocellular carcinoma in patients with chronic hepatitis b infection [99].
PubMedID- 25173229 Methods: levels of p3 and hbx mrna and status of p3 methylation were analyzed in human hepatocellular carcinoma (hcc) samples, with and without hepatitis b virus (hbv) infection, using quantitative reverse transcription-pcr and bisulfite sequencing.

Page: 1 2 3